Releaf Blog
Discover helpful insights on health, wellness, and medical cannabis in our blogs. Explore practical articles covering general medical cannabis info, tips for staying well, and how medical cannabis can assist with specific health conditions.
Latest
Decoding Cannabis: what a recent scoping review reveals about cannabis for rheumatoid arthritis
A recent scoping review has dug into how cannabinoids interact with inflammation, joint tissue, and pain signalling in rheumatoid arthritis. This article breaks down what the researchers found, how THC and CBD influence key inflammatory pathways, and what these insights may mean for people living with arthritis in the UK. We also look at how this evidence compares with current patient experiences.
The price of medical cannabis in the UK: Releaf’s costs explained
When prospective patients start to explore the world of medical cannabis, pricing strategies or how much medical cannabis costs are often at the forefront of their minds. This is completely understandable considering that to establish whether medical cannabis may be the right option for you, you need to know if it's within your budget, and therefore, the price of medical cannabis in the UK.
How Releaf patients buy THC medical cannabis legally online in the UK
In the UK, medical cannabis has been a legal treatment option since November 2018 (just over six years). Even so, a large proportion of the population remain unaware of how prescriptions for cannabis-based treatments are issued, and how patients buy medical cannabis in the UK.
From sceptic to prescriber: Dr Ali on medical cannabis for ADHD
ADHD diagnoses are on the rise, and more adults are searching for support that actually works. We spoke to Releaf psychiatrist Dr Imran Ali about what's driving the shift, why access remains a challenge, and how medical cannabis is helping some patients reduce anxiety, improve focus, and feel more in control of their symptoms.
Decoding Cannabis: Why schizophrenia is a red flag for medical cannabis
New research from Denmark has uncovered a striking connection between cannabis use disorder (CUD) and schizophrenia, with up to 30% of cases in young men potentially linked to heavy, unregulated recreational use. In this blog, we break down what the study found, how it informs Releaf’s prescribing approach, and why safeguarding vulnerable groups is essential to safe and ethical medical cannabis treatment.